Total Payments
$22,532
2024 Payments
$2,654
Companies
75
Transactions
1,904
Medicare Patients
740
Medicare Billing
$66,656
Payment Breakdown by Category
Food & Beverage$22,320 (99.1%)
Education$212.11 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,320 | 1,819 | 99.1% |
| Education | $212.11 | 85 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,915 | 271 | $0 (2024) |
| PFIZER INC. | $2,687 | 246 | $0 (2024) |
| ABBVIE INC. | $2,241 | 195 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,324 | 73 | $0 (2024) |
| Amarin Pharma Inc. | $1,291 | 80 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $817.26 | 66 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $749.72 | 83 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $687.39 | 49 | $0 (2023) |
| Lilly USA, LLC | $641.34 | 44 | $0 (2024) |
| Merck Sharp & Dohme LLC | $592.68 | 62 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,654 | 166 | ABBVIE INC. ($427.48) |
| 2023 | $2,852 | 267 | ABBVIE INC. ($495.22) |
| 2022 | $2,536 | 199 | Novo Nordisk Inc ($577.98) |
| 2021 | $3,034 | 282 | Novo Nordisk Inc ($442.35) |
| 2020 | $2,705 | 229 | PFIZER INC. ($564.69) |
| 2019 | $2,982 | 228 | PFIZER INC. ($579.98) |
| 2018 | $2,772 | 255 | PFIZER INC. ($341.62) |
| 2017 | $2,996 | 278 | PFIZER INC. ($442.73) |
All Payment Transactions
1,904 individual payment records from CMS Open Payments — Page 1 of 77
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: Obesity | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Hyperthyroidism | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 189 | 279 | $32,226 | $18,971 |
| 2022 | 3 | 166 | 236 | $28,810 | $17,301 |
| 2021 | 5 | 186 | 262 | $29,390 | $18,981 |
| 2020 | 8 | 199 | 402 | $26,014 | $11,403 |
Total Patients
740
Total Services
1,179
Medicare Billing
$66,656
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 174 | $19,140 | $9,882 | 51.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $11,220 | $8,086 | 72.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $560.00 | $411.04 | 73.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 11 | 11 | $532.51 | $368.39 | 69.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 14 | $773.08 | $223.34 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 156 | $17,160 | $8,695 | 50.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 65 | 65 | $11,050 | $8,187 | 74.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $600.00 | $419.25 | 69.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 66 | 66 | $11,220 | $8,492 | 75.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 129 | $14,190 | $7,813 | 55.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 40 | $2,600 | $1,653 | 63.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $780.00 | $780.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 15 | 15 | $600.00 | $242.85 | 40.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 75 | 147 | $16,170 | $6,148 | 38.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 23 | 23 | $3,910 | $2,617 | 66.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 19 | 19 | $1,235 | $1,159 | 93.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 20 | 93 | $2,976 | $847.46 | 28.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 28 | 28 | $1,120 | $449.64 | 40.1% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 11 | 11 | $385.00 | $121.76 | 31.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 12 | 48 | $168.00 | $47.28 | 28.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2020 | 11 | 33 | $49.50 | $13.52 | 27.3% |
About Dr. Marvin Im, D.O
Dr. Marvin Im, D.O is a Family Medicine healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154436665.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marvin Im, D.O has received a total of $22,532 in payments from pharmaceutical and medical device companies, with $2,654 received in 2024. These payments were reported across 1,904 transactions from 75 companies. The most common payment nature is "Food and Beverage" ($22,320).
As a Medicare-enrolled provider, Im has provided services to 740 Medicare beneficiaries, totaling 1,179 services with total Medicare billing of $66,656. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Dublin, OH
- Active Since 08/21/2006
- Last Updated 04/17/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154436665
Products in Payments
- Vascepa (Drug) $1,291
- Ozempic (Drug) $1,032
- NURTEC ODT (Drug) $894.21
- FARXIGA (Drug) $878.14
- XIFAXAN (Drug) $770.88
- ELIQUIS (Drug) $751.03
- CHANTIX (Drug) $663.20
- Trintellix (Drug) $654.97
- QULIPTA (Drug) $595.11
- UBRELVY (Drug) $550.57
- XARELTO (Drug) $476.61
- DUEXIS (Drug) $473.49
- Wegovy (Drug) $473.42
- JANUVIA (Drug) $450.50
- VRAYLAR (Drug) $425.90
- Saxenda (Drug) $421.23
- EUCRISA (Drug) $414.04
- Rybelsus (Drug) $400.60
- Kerendia (Drug) $371.72
- Tirosint (Drug) $366.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dublin
Dr. Robinette Huston, Md, MD
Family Medicine — Payments: $13,536
Family Medicine $13,536
David Tate, M.d, M.D
Family Medicine — Payments: $12,699
Family Medicine $12,699
Dr. Andy Williamson, M.d, M.D
Family Medicine — Payments: $11,235
Family Medicine $11,235
Mrs. Michelle Deeves, Do, DO
Family Medicine — Payments: $11,038
Family Medicine $11,038
Mr. Berrien Waters, M.d, M.D
Family Medicine — Payments: $10,563
Family Medicine $10,563
Kirkland Kolbie, M.d, M.D
Family Medicine — Payments: $10,551
Family Medicine $10,551